1. Nonpalpable prostate cancer detected in the prostate-specific antigen era

   • H. Ballentine Carter

   Editorial Pages: 329 - 330

2. Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen

   • Robert A. Stephenson
   • Janet L. Stanford

   OriginalPaper Pages: 331 - 335

3. Ultrasound findings are not useful for defining stage Tic prostate cancer

   • Holt Sanders
   • Rizk El-Galley

   OriginalPaper Pages: 336 - 338

4. Comparison of pathologic characteristics of T1c and non-Tic cancers detected in a population-based screening study, the European randomized study of screening for prostate cancer

   • Robert F. Hoedemaeker
   • John B. W. Rietbergen
   • Fritz H. Schröder

   OriginalPaper Pages: 339 - 345

5. Stage T1c prostate cancer: defining the appropriate staging evaluation and the role for pelvic lymphadenectomy

   • Mario C. Beduschi
   • Ricardo Beduschi
   • Joseph E. Oesterling

   OriginalPaper Pages: 346 - 358

6. Prediction of significant cancer in men with stage Tic adenocarcinoma of the prostate

   • H. Ballentine Carter
   • Jonathan I. Epstein

   OriginalPaper Pages: 359 - 363

7. Expectant management as an option for men with stage T1c prostate cancer: a preliminary study

   • James L. Mohler
   • Bernadette T. Williams
   • J. L. Mohler

   OriginalPaper Pages: 364 - 368

8. Radiation therapy as treatment for stage T1c prostate cancers

   • Gerald E. Hanks
   • Alexandra L. Hanlon
   • Timothy E. Schultheiss

   OriginalPaper Pages: 369 - 372

9. Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer

   • Charles R. Pound
   • Patrick C. Walsh
   • Alan W. Partin

   OriginalPaper Pages: 373 - 377

10. Advances in the evaluation and treatment of the infertile man

    • Edward D. Kim
    • Larry I. Lipshultz

    Free paper Pages: 378 - 393

11. Announcement

    Announcement Pages: 394 - 394